
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇳🇱NL · Alternative Health#1241K to 10K
- 🇩🇰DK · Alternative Health#183500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
450 to 3.9K🎙 Daily cadence·182 episodes·Last published 3d ago - Monthly Reach
Unique listeners across all episodes (30 days)
1.5K to 13K🇳🇱77%🇩🇰23% - Active Followers
Loyal subscribers who consistently listen
600 to 5.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 15 epsHost
Recent guests
No guests detected in recent episodes.
Recent episodes
Hormone Replacement Therapy Explained: What Every Woman Needs to Know | Episode 1
Jul 2, 2026
31m 59s
The Hidden Risks of Oral Estrogen: What Every Woman Should Know About Estrone
Jun 25, 2026
27m 42s
Estradiol Explained: The Truth About Oral Estrogen, Estrone, Testosterone & Informed Consent
Jun 18, 2026
19m 24s
What Every Woman Needs to Hear About Health, Food & Healing
Jun 11, 2026
16m 02s
The 6-Week Nutrition Reset I Use With Patients
Jun 4, 2026
27m 07s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/2/26 | ![]() Hormone Replacement Therapy Explained: What Every Woman Needs to Know | Episode 1 | Hormone Replacement Therapy (HRT) is far more than simply taking estrogen or progesterone. In this first episode of a new 36-part series, Dr. Brendan McCarthy explains why hormone therapy should never be viewed as a one-size-fits-all treatment. From puberty through menopause, he explores how hormones change throughout a woman's life, why lab testing matters, and how personalized care leads to better outcomes. You'll learn the differences between estradiol, estrone, estriol, progesterone vs. progestins, testosterone therapy, delivery methods, and why true informed consent is essential when making decisions about your health. In this episode: ✔️ Why "HRT" is an oversimplified term✔️ The different types of estrogen and why they matter✔️ Progesterone vs. synthetic progestins✔️ Testosterone therapy for women explained✔️ Why hormone testing and lab work are critical✔️ Oral vs. topical vs. injectable vs. pellet hormone therapy✔️ How inflammation, stress, sleep, nutrition, and metabolism affect hormones✔️ Why hormone health starts long before menopause✔️ What informed consent should actually look like in medicine This episode lays the foundation for the next 36 episodes, where Dr. McCarthy breaks down hormone therapy into practical, easy-to-understand lessons so you can become a more informed advocate for your own health. 📚 Download the free research resources and citations:Visit www.protealife.com for episode notes, references, and educational materials. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He’s also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you’re ready to take your health seriously, this podcast is a great place to start. 👇 Tap Subscribe to learn more about what’s actually happening in your body, and what to do about it. 📘 Read Dr. McCarthy’s Book:Jump Off the Mood Swing – A Sane Woman’s Guide to Her Crazy Hormoneshttps://www.amazon.com/Jump-Off-Mood-... 📲 Follow Dr. McCarthy:Instagram: @drbrendanmccarthyTikTok: @drbrendanmccarthyWebsite: www.protealife.com 💬 Got a question or topic for a future episode? Let us know in the comments! | 31m 59s | ||||||
| 6/25/26 | ![]() The Hidden Risks of Oral Estrogen: What Every Woman Should Know About Estrone | Many women are prescribed oral estrogen without ever being told what happens after it enters the body. In this episode, Dr. Brendan McCarthy takes a deeper look at estrone, the estrogen metabolite created when estradiol is taken orally, and explains why the delivery method of hormone therapy matters. You'll learn: The difference between estradiol and estrone Why oral estrogen creates significantly higher estrone levels How estrone may contribute to inflammation and insulin resistance The connection between estrogen metabolism and weight gain during perimenopause and menopause Why monitoring labs is essential when using hormone therapy The importance of understanding risks, benefits, and treatment options before starting hormones Dr. McCarthy also discusses the role of inflammation, body fat, metabolic health, and hormone delivery systems in creating long-term outcomes for women navigating menopause. This episode is about education, informed consent, and helping women better understand the science behind their care. Citations: There is more than one estrogen; after menopause, estrone dominates Kuhl, Herbert. “Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration.” Climacteric, vol. 8, no. S1, 2005, pp. 3–63. Body fat is an endocrine organ — aromatase converts androstenedione into estrone, and adipose becomes the dominant post-menopausal estrogen source Lee, Angel A., and Laura J. Den Hartigh. “Metabolic Impact of Endogenously Produced Estrogens by Adipose Tissue in Females and Males across the Lifespan.” Frontiers in Endocrinology, vol. 16, 2025, article 1682231. Inflamed fat raises IL-6; IL-6 tracks the insulin-resistant state Kern, Philip A., et al. “Adipose Tissue Tumor Necrosis Factor and Interleukin-6 Expression in Human Obesity and Insulin Resistance.” American Journal of Physiology-Endocrinology and Metabolism, vol. 280, no. 5, 2001, pp. E745–E751. IL-6 is part of the insulin-resistance machinery — it correlates with impaired insulin-stimulated glucose uptake Bastard, Jean-Philippe, et al. “Adipose Tissue IL-6 Content Correlates with Resistance to Insulin Activation of Glucose Uptake Both In Vivo and In Vitro.” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 5, 2002, pp. 2084–2089. Inflammation amplifies aromatase — IL-6 raises aromatase via COX-2/PGE2 Bowers, Laura W., et al. “Obesity-Associated Systemic Interleukin-6 Promotes Pre-Adipocyte Aromatase Expression via Increased Breast Cancer Cell Prostaglandin E2 Production.” Breast Cancer Research and Treatment, vol. 149, no. 1, 2015, pp. 49–57. Human-tissue confirmation: HOMA-IR, IL-6, insulin, leptin, hsCRP track breast aromatase after menopause Brown, Kristy A., et al. “Menopause Is a Determinant of Breast Aromatase Expression and Its Associations with BMI, Inflammation, and Systemic Markers.” The Journal of Clinical Endocrinology & Metabolism, vol. 102, no. 5, 2017, pp. 1692–1701. Iyengar, Neil M., et al. “Effects of Obesity on Breast Aromatase Expression and Systemic Metabo-Inflammation in Women with BRCA1 or BRCA2 Mutations.” npj Breast Cancer, vol. 7, no. 1, 2021, article 18. The molecular crux: estrone drives ERα/NF-κB inflammatory signaling while estradiol opposes it Qureshi, Rehana, et al. “The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development.” Cell Metabolism, vol. 31, no. 6, 2020, pp. 1154–1172.e9. Estrone as a metabolic-risk signal — prospectively associated with diabetes (note: male cohort) Jasuja, Guneet Kaur, et al. “Circulating Estrone Levels Are Associated Prospectively with Diabetes Risk in Men of the Framingham Heart Study.” Diabetes Care, vol. 36, no. 9, 2013, pp. 2591–2596. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, | 27m 42s | ||||||
| 6/18/26 | ![]() Estradiol Explained: The Truth About Oral Estrogen, Estrone, Testosterone & Informed Consent | In this episode, Dr. Brendan McCarthy breaks down one of the most misunderstood topics in hormone replacement therapy: estradiol. Not all estrogen is the same—and how estradiol is delivered can dramatically affect hormone balance, inflammation, clotting risk, testosterone levels, and overall health outcomes. Dr. McCarthy discusses: • Why route of administration matters (oral, patch, injectable, topical, vaginal, pellet)• How oral estradiol converts to estrone• The differences between estradiol (E2), estrone (E1), and estriol (E3)• Estrone's relationship to inflammation and metabolic health• Oral estrogen and clotting risk• Oral estrogen's effect on SHBG and free testosterone• The impact of oral estrogen on IGF-1 and growth hormone signaling• Why informed consent should be central to hormone therapy• Benefits and limitations of pellets, patches, creams, and injections• Estriol and emerging research in autoimmune conditions such as multiple sclerosis At Protea Medical Center, our philosophy is simple: patients deserve complete information so they can make empowered decisions about their health. 📍 Protea Medical CenterTempe, Arizona 👍 If you found this episode helpful, please like, subscribe, and share it with someone who may benefit. ⚠️ This podcast is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your treatment plan. REFERENCES (Abbreviated) • Kuhl H. Climacteric. 2005.• O'Connell MB. J Clin Pharmacol. 1995.• Canonico M et al. Circulation. 2007.• Vinogradova Y et al. BMJ. 2019.• Weissberger AJ et al. JCEM. 1991.• Bellantoni MF et al. JCEM. 1996.• Kam GY et al. JCEM. 2000.• Brown KA et al. JCEM. 2017.• Iyengar NM et al. npj Breast Cancer. 2021.• Bowers LW et al. Breast Cancer Res Treat. 2015.• Lee AA & Den Hartigh LJ. Front Endocrinol. 2025.• Kern PA et al. Am J Physiol Endocrinol Metab. 2001.• Bastard JP et al. JCEM. 2002.• Qureshi R et al. Cell Metab. 2020.• Cushman M et al. Circulation. 1999.• Key TJ et al. J Natl Cancer Inst. 2002.• Sicotte NL et al. Ann Neurol. 2002.• Voskuhl RR et al. Lancet Neurol. 2016.• Soldan SS et al. J Immunol. 2003.• Taylor MB & Gutierrez MJ. Pharmacotherapy. 2008.• FDA Drug Safety Communication. 2010.• Greenblatt RB & Suran RR. Am J Obstet Gynecol. 1949. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He’s also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you’re ready to take your health seriously, this podcast is a great place to start. 👇 Tap Subscribe to learn more about what’s actually happening in your body, and what to do about it. 📘 Read Dr. McCarthy’s Book:Jump Off the Mood Swing – A Sane Woman’s Guide to Her Crazy Hormoneshttps://www.amazon.com/Jump-Off-Mood-... 📲 Follow Dr. McCarthy:Instagram: @drbrendanmccarthyTikTok: @drbrendanmccarthyWebsite: www.protealife.com 💬 Got a question or topic for a future episode? Let us know in the comments! | 19m 24s | ||||||
| 6/11/26 | ![]() What Every Woman Needs to Hear About Health, Food & Healing✨ | healthfood+5 | — | Protea Medical Center | — | healthfood cravings+5 | — | 16m 02s | |
| 6/4/26 | ![]() The 6-Week Nutrition Reset I Use With Patients✨ | nutritionweight management+4 | — | — | — | nutrition resetultra-processed eating+4 | — | 27m 07s | |
| 5/28/26 | ![]() The 9-Minute Method to Break Food Cravings✨ | emotional eatingfood cravings+3 | — | Food Cue Reactivity and Craving Predict Eating and Weight Gain: A Meta-Analytic ReviewLiking, Wanting, and the Incentive-Sensitization Theory of Addiction+2 | — | food cravingsemotional eating+5 | — | 27m 04s | |
| 5/21/26 | ![]() The Exit Strategy: How to Escape the Ultra-Processed Food Loop✨ | ultra-processed foodsemotional eating+4 | — | — | — | ultra-processed foodsemotional discomfort+6 | — | 31m 34s | |
| 5/14/26 | ![]() The Shame Trap of Ultra-Processed Foods✨ | ultra-processed foodscompulsive eating+4 | — | — | — | ultra-processed foodscompulsive eating+6 | — | 29m 17s | |
| 5/7/26 | ![]() Trauma Is Driving Your Diet (Not Willpower) | Ultra-Processed Foods Explained✨ | traumadiet+5 | — | Protea Medical CenterSubstance Abuse and Mental Health Services Administration+2 | — | traumadiet+8 | — | 23m 45s | |
| 4/30/26 | ![]() Women, Hormones & Cholesterol: The Hidden Role of Ultra-Processed Foods✨ | Cardiovascular disease in womenUltra-processed foods+4 | — | American Heart AssociationUltra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake+1 | — | cardiovascular diseasewomen's health+5 | — | 17m 25s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/23/26 | ![]() Ultra-Processed Foods & Autoimmunity✨ | autoimmunityultra-processed foods+4 | — | Cell MetabolismUltra-Processed Foods & Autoimmunity+1 | — | autoimmunityultra-processed foods+6 | — | 18m 30s | |
| 4/16/26 | ![]() The Truth About GLP-1s✨ | GLP-1 medicationsweight management+4 | — | semaglutidetirzepatide+1 | — | GLP-1semaglutide+6 | — | 15m 03s | |
| 4/9/26 | ![]() This Was Never a Fair Fight: How Ultra-Processed Food Trains a Child’s Brain✨ | ultra-processed foodchild brain development+4 | — | Public Health NutritionCell Metabolism+2 | — | ultra-processed foodshyper-palatable+5 | — | 21m 22s | |
| 4/2/26 | ![]() This Isn’t a Willpower Problem: The Truth About Stress, Cravings & Weight Gain✨ | stresscravings+4 | — | Protea Medical CenterStress Weakens Prefrontal Networks: Molecular Insults to Higher Cognition+1 | — | stresscravings+5 | — | 23m 55s | |
| 3/26/26 | ![]() The Real Reason You Crave Junk Food Under Stress✨ | stress and cravingsweight gain+4 | — | Protea Medical Center | — | junk foodstress+5 | — | 18m 15s | |
| 3/19/26 | ![]() The Missing Piece in Weight Loss✨ | weight losscalorie restriction+5 | — | Protea Mechanism-Anchored Evidence MapHall et al.+3 | — | weight losscalories+5 | — | 19m 36s | |
| 3/12/26 | ![]() Why You’re Still Hungry After Eating✨ | hungercravings+5 | — | Protea Medical Center | Tempe, Arizona | hungercravings+7 | — | 21m 01s | |
| 3/5/26 | ![]() Why You Can’t Stop Craving Ultra-Processed Foods (It’s Not Willpower)✨ | ultra-processed foodscravings+4 | — | — | — | cravingsultra-processed foods+6 | — | 15m 47s | |
| 2/25/26 | ![]() Ultra-Processed Foods: Why You Can’t Stop Eating Them | If you're a woman in your late 30s, 40s, or 50s and you feel swollen, inflamed, stuck, exhausted, or like your body has completely turned against you — this series is for you. Let’s be clear:This is NOT a diet episode.This is NOT food shaming.This is NOT about willpower. This is upstream endocrinology. In this episode, Dr. McCarthy explains: Why weight gain in perimenopause is not a discipline problem How estrogen dominance and low progesterone shift insulin sensitivity Why stress hormones (like cortisol) amplify fat storage How ultra-processed, hyper-palatable foods hijack your brain Why traditional diets (keto, low-fat, carnivore) often fail women The real role of insulin as a routing hormone — not just a blood sugar hormone Why GLP-1 medications can help — but shouldn’t become “handcuffs” Most nutrition research was built on male physiology.You are not a small man.And it was never a fair fight. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He’s also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you’re ready to take your health seriously, this podcast is a great place to start. 👇 Tap Subscribe to learn more about what’s actually happening in your body, and what to do about it. 📘 Read Dr. McCarthy’s Book: Jump Off the Mood Swing – A Sane Woman’s Guide to Her Crazy Hormones https://www.amazon.com/Jump-Off-Mood-Swing-Hormones/dp/0999649604 📲 Follow Dr. McCarthy: Instagram: @drbrendanmccarthy TikTok: @drbrendanmccarthy Website: www.protealife.com 💬 Got a question or topic for a future episode? Let us know in the comments! | 17m 27s | ||||||
| 2/18/26 | ![]() The Progesterone Promise: Why Context Matters More Than the Hype | In this final episode of the Progesterone Promise series, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, breaks down one of the most misunderstood hormones in women’s health: progesterone. Progesterone is not “good” or “bad.” It’s contextual. In today’s world of quick sound bites and social media medicine, hormones are often reduced to oversimplified claims like “progesterone fixes anxiety” or “progesterone causes breast cancer.” The truth? It depends on your body, your stress levels, your liver health, your inflammation, your delivery method, and whether you're using bioidentical progesterone or synthetic progestins. Citations: 1. Oral Progesterone → First-Pass Metabolism & Allopregnanolone Claim:Oral micronized progesterone undergoes significant hepatic first-pass metabolism, increasing neuroactive metabolites (especially allopregnanolone), which positively modulate GABA-A receptors and produce sedative/anxiolytic effects. Core Evidence: Simon et al., 1993; de Lignières et al., 1995; Freeman et al., 1990 — Oral progesterone produces measurable neuroactive metabolites. Paul & Purdy, 1992; Rupprecht et al., 2001 — Allopregnanolone enhances GABA-A receptor activity. Supports:Sedation variability by route • Neurosteroid generation • GABA-A modulation 2. Sulfation vs 5α-Reduction → Opposing Neurologic Effects Claim:Progesterone metabolites can produce calming (5α-reduced) or excitatory (sulfated) neurologic effects depending on enzyme routing. Core Evidence: Majewska et al., 1990 — Pregnenolone sulfate negatively modulates GABA-A. Wu et al., 1991 — Sulfated neurosteroids enhance NMDA signaling. Schumacher et al., 2007; Reddy, 2010 — Pathway reviews of sulfation vs 5α-reduction. Supports:Reverse responding hypothesis • Divergent neurologic experiences • Enzyme-dependent effects 3. Stress & Enzyme Modulation Claim:Chronic stress alters HPA axis tone and hepatic enzyme expression, influencing steroid metabolism balance. Core Evidence: McEwen, 1998 — Allostatic load model. Charmandari et al., 2005 — Cortisol’s systemic regulatory effects. Zanger & Schwab, 2013; Gibson & Skett, 2001 — Stress alters cytochrome P450 expression. Supports:Stress-biased metabolism • Context-dependent hormone response 4. Breast Tissue Signaling & Context Claim:Progesterone influences mammary differentiation and interacts with estrogen signaling in context-dependent ways. Core Evidence: Brisken & O’Malley, 2010 — Progesterone receptor biology in breast tissue. Beleut et al., 2010 — RANKL mediates progesterone-driven proliferation. Hofseth et al., 1999 — PR-ER signaling interaction. Stanczyk & Bhavnani, 2014 — Natural vs synthetic differences in breast effects. Supports:Lobuloalveolar differentiation • RANKL pathway • Context-dependent proliferation 5. Synthetic Progestins vs Bioidentical Progesterone Claim:Synthetic progestins differ structurally and bind off-target receptors, producing distinct tissue effects. Core Evidence: Stanczyk et al., 2013 — Receptor binding differences. Sitruk-Ware, 2004 — Biologic comparisons. Chlebowski et al., 2003 (WHI) — Breast cancer signal with CEE + MPA. Supports:Structural divergence • Receptor-level differences • WHI clarification 6. Route of Delivery Differences Claim:Oral, vaginal, transdermal, and sublingual progesterone produce distinct pharmacokinetic profiles and tissue targeting. Core Evidence: Simon, 1995 — Oral vs vaginal PK comparison. Cicinelli et al., 2000 — “First uterine pass effect.” Wren et al., 2003 — Route-dependent systemic levels. Supports:Uterine targeting • Neurosteroid variability • Sedation differences 7. Progesterone, PMS & Migraine Claim:Neurosteroid fluctuations influence GABAergic tone and may contribute to PMS and migraine susceptibility. Core Evidence: Backstrom et al., 2011 — Allopregnanolone fluctuations in PMS. Reddy & Rogawski, 2002 — Neurosteroids and seiz | 27m 54s | ||||||
| 2/12/26 | ![]() Progesterone & Breast Health: What Women Were Never Properly Taught | In this episode of the progesterone series, Dr. Brendan McCarthy — Chief Medical Officer of Protea Medical Center in Tempe, Arizona — explores the often misunderstood relationship between progesterone, estrogen, and breast health. For decades, women have been taught to fear their breasts and fear hormones. While awareness matters, fear is disempowering — and it has left many women confused about what’s actually happening in their bodies. In this episode, we discuss: Why breast tissue is dynamic, not static How estrogen stimulates growth and progesterone restores balance The role of progesterone in breast tissue maturation and architecture Why dense or fibrocystic breasts often reflect unopposed estrogen How restoring ovulation and progesterone can reduce breast pain and density in some women The difference between natural progesterone vs synthetic progestins Where the fear around progesterone and breast cancer really came from Progesterone is not something to fear — it is a hormone of organization, balance, and maturation. Understanding how it works allows women to approach breast health with clarity instead of anxiety. 👍 If this episode was helpful, please like, subscribe, and share it with someone who needs this information.💬 Comments are read and appreciated. Citations: (Provided for educational purposes; this episode discusses biologic frameworks and observational data, not medical guarantees.) ⸻ Korenman SG. Estrogen window hypothesis (1980) Korenman SG. The etiology of breast cancer: hormone factors.Cancer. 1980;46(4 Suppl):874–880. Context:This paper introduced what later became known as the “estrogen window” hypothesis—the idea that prolonged estrogen-driven proliferation without adequate progesterone signaling may create periods of increased tissue vulnerability. This is a mechanistic framework, not a prevention claim, but it remains foundational in how endocrinologists think about hormonal timing and breast biology. ⸻ Estrogen as a proliferative signal in breast tissue Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.Eur J Cancer Clin Oncol. 1988;24(1):29–43. Context:Establishes estrogen’s role as a mitogenic (growth-promoting) signal in breast epithelium and frames cancer risk partly in terms of cumulative proliferative exposure over time. ⸻ Progesterone and breast differentiation biology Brisken C, O’Malley B. Hormone action in the mammary gland.Cold Spring Harb Perspect Biol. 2010;2(12):a003178. Context:Describes progesterone’s role in lobuloalveolar development, differentiation, and architectural organization in breast tissue. Supports the concept that progesterone signaling is biologically distinct from estrogen-driven proliferation. ⸻ Fibrocystic breast change and hormonal signaling Sitruk-Ware R. Hormonal replacement therapy and the breast.Menopause. 2002;9(4):237–251. Context:Reviews how different hormonal environments influence benign breast changes, including pain, nodularity, and cystic architecture, and discusses differential tissue effects of estrogen and progesterone signaling. ⸻ Mammographic density and hormonal influence Boyd NF et al. Mammographic density and the risk and detection of breast cancer.N Engl J Med. 2007;356:227–236. Context:Establishes mammographic density as a biologic and radiographic marker influenced by hormonal, stromal, and epithelial factors. Density reflects tissue composition rather than disease itself. ⸻ Bioidentical progesterone vs synthetic progestins (E3N cohort) Fournier A et al. Breast cancer risk in relation to different types of hormone replacement therapy.Int J Cancer. 2005;114(3):448–454. Context:Large observational cohort suggesting that estrogen combined with synthetic progestins was associated with higher breast cancer risk, whereas estrogen combined with micronized progesterone did not show the same risk signal. Observational data—not proof of protection. ⸻ Systemati | 13m 17s | ||||||
| 2/5/26 | ![]() Prolactin: The Overlooked Hormone Behind Unexplained Infertility & Low Progesterone | Unexplained infertility, PMS, and low progesterone are often dismissed when labs fall “within range.” In this episode, Dr. Brendan McCarthy explains why prolactin may be the missing piece. Learn how mildly elevated prolactin can suppress ovulation, lower progesterone, and impact fertility—even when labs appear normal. We also discuss common causes, symptoms, the role of stress and medications, and why diet (including gluten sensitivity) may matter. This episode focuses on precision medicine, not fear—helping you understand what standard reference ranges often miss. Citations: Research — Prolactin and Breast Cancer Risk Below are key epidemiologic and review papers that inform the discussion in this episode regarding prolactin and breast biology. These studies look at associations, not simple cause-and-effect relationships, and help explain why prolactin shows up in breast health conversations. Meta-analysis: circulating prolactin and breast cancer risk Wang M, et al. (2016).Plasma prolactin and breast cancer risk: a meta-analysis.Cancer Causes & Control. This meta-analysis pooled data from multiple observational studies comparing women with higher versus lower circulating prolactin levels. Across studies, higher prolactin levels were associated with a modest but statistically significant increase in breast cancer risk. The association was most evident in postmenopausal women and in hormone-receptor–positive tumors. This helps explain why prolactin is considered a relevant growth signal in breast tissue rather than just a “lactation hormone.” Systematic review and meta-analysis: prolactin levels across breast cancer cohorts Aranha AF, et al. (2022).Impact of prolactin levels in breast cancer: a systematic review and meta-analysis.Endocrine-Related Cancer. This more recent systematic review and meta-analysis evaluated circulating prolactin levels across breast cancer populations and control groups. Elevated prolactin levels were associated with higher breast cancer occurrence, with stronger associations seen in invasive cancers and hormone-receptor–positive disease. This paper adds weight to the idea that prolactin participates in breast biology in ways that matter clinically, even outside of pregnancy and breastfeeding. Prospective cohort studies: prolactin measured before diagnosis Tworoger SS, et al. (2004; 2006).Prospective analyses from large cohorts including the Nurses’ Health Study. In these studies, prolactin was measured years before any breast cancer diagnosis. Women with higher prolactin levels had a higher likelihood of developing breast cancer later, particularly estrogen-receptor–positive tumors in postmenopausal women. Because prolactin was measured before cancer developed, these studies help clarify timing and reduce the concern that elevated prolactin is simply a consequence of disease. Mechanistic context (supportive background) Experimental and translational studies show that prolactin receptor signaling influences mammary epithelial cell growth, differentiation, and interaction with estrogen signaling pathways. This provides a biologic backdrop for why epidemiologic associations between prolactin and breast cancer risk keep appearing across different study designs. How to read this as a clinician or patient These data do not mean prolactin “causes” breast cancer in a simple or deterministic way. What they do show is that prolactin is an active hormone in breast tissue, and chronically higher levels are consistently associated with changes in breast risk profiles across large populations. That’s why prolactin deserves attention in conversations about fertility, breast symptoms, and long-term hormonal signaling—not fear, and not dismissal. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause m | 15m 21s | ||||||
| 1/28/26 | ![]() Progesterone, Stress & the “Progesterone Steal” Explained | In this episode of our progesterone series (Episode 5), Dr. Brendan McCarthy — Chief Medical Officer of Protea Medical Center in Tempe, Arizona — breaks down the often-misunderstood relationship between stress, ovulation, progesterone, and cortisol. We explore the concept commonly referred to as the “progesterone steal” and why this term can be misleading. Rather than hormones being “stolen,” Dr. McCarthy explains how the body intelligently reroutes hormone production under stress to prioritize survival over reproduction. This episode covers: Why the body must feel safe to ovulate and produce progesterone How chronic stress impacts PMS, fertility, and cycle regularity The truth about cortisol (and why it isn’t the villain it’s often made out to be) Why low progesterone is not a personal failure or flaw Why you can’t medicate someone out of stress — and what good medicine actually looks like This conversation is about biology, not blame. Your body is not broken — it’s responding exactly as designed. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He’s also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you’re ready to take your health seriously, this podcast is a great place to start. 👇 Tap Subscribe to learn more about what’s actually happening in your body, and what to do about it. 📘 Read Dr. McCarthy’s Book: Jump Off the Mood Swing – A Sane Woman’s Guide to Her Crazy Hormones https://www.amazon.com/Jump-Off-Mood-Swing-Hormones/dp/0999649604 📲 Follow Dr. McCarthy: Instagram: @drbrendanmccarthy TikTok: @drbrendanmccarthy Website: www.protealife.com 💬 Got a question or topic for a future episode? Let us know in the comments! | 24m 48s | ||||||
| 1/22/26 | ![]() Progesterone: Why Delivery Method Matters for Brain, Uterus & Breast Health | In this episode, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, explains why progesterone delivery systems matter—and how different routes change what progesterone actually does in the body. Part 4 of the progesterone series covers oral, topical, vaginal, rectal, injectable, and sublingual progesterone, breaking down which methods affect the brain, uterus, and breast tissue—and why choosing the right route is critical. If progesterone hasn’t worked for you in the past, the issue may not be the dose, but how it was delivered. This episode focuses on education, patient agency, and thoughtful hormone care—no shortcuts, no selling. Subscribe for more in-depth conversations on hormones and women’s health, and share with someone who may benefit. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He’s also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you’re ready to take your health seriously, this podcast is a great place to start. 👇 Tap Subscribe to learn more about what’s actually happening in your body, and what to do about it. 📘 Read Dr. McCarthy’s Book: Jump Off the Mood Swing – A Sane Woman’s Guide to Her Crazy Hormones https://www.amazon.com/Jump-Off-Mood-Swing-Hormones/dp/0999649604 📲 Follow Dr. McCarthy: Instagram: @drbrendanmccarthy TikTok: @drbrendanmccarthy Website: www.protealife.com 💬 Got a question or topic for a future episode? Let us know in the comments! | 28m 26s | ||||||
| 1/15/26 | ![]() Reverse Responding to Progesterone: Why Your Body Isn’t Failing You | If progesterone makes you feel wired, anxious, angry, emotional, or unable to sleep, this episode is for you. In this deeply important continuation of our reverse responding series, Dr. Brendan McCarthy—Chief Medical Officer of Protea Medical Center—returns to clarify what was missing in Episode 3C and to walk you through the real physiology, compassion, and treatment strategy behind reverse responding. Reverse responding is not intolerance, weakness, anxiety, noncompliance, or failure. It is an adaptive response rooted in threat-state physiology, chronic stress, and lived experience. Your body is not broken—it is protecting you. In this episode, Dr. McCarthy covers: What reverse responding actually is (and what it is not) The difference between sulfation and 5-alpha pathways Why labs often miss this entirely Why “just more progesterone” makes things worse How trauma, chronic stress, and safety shape hormone response The importance of earning permission from the nervous system Practical treatment pillars: Glycemic stability Circadian safety and sleep rhythm Reducing inflammatory load Gentle nervous system regulation Slow, low, respectful progesterone onboarding Supplement strategies used clinically (and what to avoid) Most importantly, this episode is a reminder:You are not the problem. Your body is doing something intelligent. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he’s helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He’s also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you’re ready to take your health seriously, this podcast is a great place to start. 👇 Tap Subscribe to learn more about what’s actually happening in your body, and what to do about it. 📘 Read Dr. McCarthy’s Book: Jump Off the Mood Swing – A Sane Woman’s Guide to Her Crazy Hormones https://www.amazon.com/Jump-Off-Mood-Swing-Hormones/dp/0999649604 📲 Follow Dr. McCarthy: Instagram: @drbrendanmccarthy TikTok: @drbrendanmccarthy Website: www.protealife.com 💬 Got a question or topic for a future episode? Let us know in the comments! | 38m 13s | ||||||
Showing 25 of 191
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.
